Connection
Sue Griffin to Alzheimer Disease
This is a "connection" page, showing publications Sue Griffin has written about Alzheimer Disease.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.161 |
|
|
|
-
Griffin WS. Excess betaCTF, not Abeta: the culprit in Alzheimer-related endocytic dysfunction. Proc Natl Acad Sci U S A. 2010 Jan 26; 107(4):1263-4.
Score: 0.258
-
Chopra MP, Landes RD, Jones RA, Feldman ZL, Beck C, Griffin ST. Does the apolipoprotein E epsilon 4 genotype influence the expression of depression with cognitive impairment? Int J Geriatr Psychiatry. 2009 Jun; 24(6):650-2.
Score: 0.247
-
Griffin WS. Perispinal etanercept: potential as an Alzheimer therapeutic. J Neuroinflammation. 2008 Jan 10; 5:3.
Score: 0.224
-
Griffin WS. Inflammation and neurodegenerative diseases. Am J Clin Nutr. 2006 Feb; 83(2):470S-474S.
Score: 0.196
-
Griffin WS, Mrak RE. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J Leukoc Biol. 2002 Aug; 72(2):233-8.
Score: 0.154
-
Aboud O, Mrak RE, Boop FA, Griffin WS. Epilepsy: neuroinflammation, neurodegeneration, and APOE genotype. Acta Neuropathol Commun. 2013 Jul 29; 1:41.
Score: 0.082